Kastalia Medrano 
White House Meth Plan Still Includes Harm Reduction, Just Not for Meth
Once the federal government designated methamphetamine an “emerging drug threat” in March 2022, the ...
Ohio Bans More Nitazenes, Claiming They Cause Deaths on Their Own
Ohio has temporarily banned nine nitazene analogs as Schedule I controlled substances, making sale ...
New National Drug Control Strategy: Almost More Harm Reduction Access
In 2022, the White House released a National Drug Control Strategy that it widely ...
VT Gov. Vetoes Safe Consumption Site Bill. It May Become Law Without Him.
Vermont Governor Phil Scott (R) has vetoed legislation that would authorize a safe consumption ...
Amid DEA War on Meth, Cocaine Is at Last a “Traditional Plant-Based Drug”
The 2020 National Drug Threat Assessment (NDTA) is such a widely cited document partly ...
Walgreens Rolls Out $34.99 Naloxone, as Generics and OTC Gain Ground
Walgreens is rolling out an over-the-counter (OTC) naloxone nasal spray, which it will sell ...
The Opioid Settlements Being Paid in Naloxone Don’t Quite Add Up
Amneal Pharmaceuticals, a New Jersey-based manufacturer known for generics, has agreed to settle the ...
The Delaware Mass Overdose Drugs Aren’t “Naloxone-Resistant”
On April 30, Delaware State Police (DSP) and the Delaware Department of Health and ...
FDA Approves Even Higher-Dose Naloxone Nasal Spray, Again
The Food and Drug Administration has approved a new naloxone nasal spray that contains ...
If Abstinence Isn’t the Point of Contingency Management, What Is?
There aren’t any treatments for stimulant use disorder (SUD) that have strong evidence, but ...
